This website uses its own as well as third-party cookies to enhance your browsing experience and provide you with a better service. By continuing to browse this website, we understand that you agree to the Universitat Jaume I cookie policy.
More information
Introducción: La leucemia aguda mieloide (LAM) precisa tratamiento quimioterápico mielosupresivo y provoca múltiples comorbilidades. Tras cada consolidación, se realizaba seguimiento ambulatorio con frecuentes reingresos ...